A detailed history of Aqr Capital Management LLC transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 69,471 shares of TSHA stock, worth $127,131. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,471
Holding current value
$127,131
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.01 - $2.46 $139,636 - $170,898
69,471 New
69,471 $139,000
Q2 2022

Aug 15, 2022

BUY
$2.47 - $6.77 $25,030 - $68,607
10,134 New
10,134 $38,000

Others Institutions Holding TSHA

About Taysha Gene Therapies, Inc.


  • Ticker TSHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,359,500
  • Market Cap $88.5M
  • Description
  • Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...
More about TSHA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.